Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver or kidney injury
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
Questions have often been raised about the effects of ashwagandha on the liver and kidneys. Now, a large clinical study has found no evidence of liver or kidney damage after 24 weeks of standardized ashwagandha root extract. This study was published in the medical journal Frontiers in Medicine.
Ashwagandha Safety: 24-Week Trial Shows No Liver or Kidney Injury
A recent large-scale clinical study has evaluated the prolonged use of a standardised Ashwagandha root extract, reporting a favourable safety and tolerability profile over a 24-week period. Published in Frontiers in Medicine, the multicentre research investigated the effects of the herbal extract on apparently healthy adults who had previously received a COVISHIELD vaccination. The randomised, double-blind, placebo-controlled trial was carried o…
Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver or kidney injury - tennews.in: National News Portal
New Delhi, Sep 28 (IANS) A large multicentre clinical study published in Frontiers in Medicine found daily administration of a standardised Ashwagandha root extract for 24 weeks was well tolerated with no evidence of treatment‑related hepatic or renal injury, the government said on Monday. The statement from the Ministry of Ayush said the study published […] The post Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver…
Ashwagandha Liver Injury: What The TGA's July 2026 Safety Update Actually Says About 11 Cases
The herb sold in Australia as ashwagandha is Withania somnifera, and it has crossed from the Indian grocer to the pharmacy chain and the supplement aisle, sold for stress, sleep and recovery to people who have never heard the word Ayurveda. In July 2026 the Therapeutic Goods Administration published a medicine safety update on it, its second in two and a half years. The regulator’s own phrase for the ashwagandha liver risk is very rare. It is al…
Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver or kidney injury
Digital Desk | New Delhi, Sep 28 (IANS) A large multicentre clinical study published in Frontiers in Medicine found daily administration of a standardised Ashwagandha root extract for 24 weeks was well tolerated with no evidence of treatment‑related hepatic or renal injury, the government said on Monday. The statement from the Ministry of Ayush said the study published on August 20 is based on a multicentre, randomised, double‑blind, placebo‑c…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
